Skip to main content
Home

Search form

  • ABOUT US
    • ECFS Society Details
      • Society Information
      • Applications for Support
    • ECFS Membership
      • Membership Subscription
      • Membership Demographics
    • Other Information
      • Latest News
      • Job Opportunities
      • Grants and Programmes
      • Links
  • RESEARCH
    • ECFS Projects
      • ECFS Clinical Trials Network
      • ECFS Patient Registry
    • ECFS Working Groups
      • Diagnostic Network
      • Exercise
      • Neonatal Screening
      • Fungal Pathogens
      • Pulmonary Exacerbation
    • Special Projects
      • ECFS / CF Europe Post-Doctoral Research Fellowship
      • CFQ-R questionnaire and CF candidates for lung transplant
      • EU funded projects
      • MucoFong International Project
      • Complete CFTR gene mutation analysis in European patients with Cystic Fibrosis
    • Past Working Groups
      • Cystic Fibrosis Molecular and Cell Biology and Physiology Basic Science
      • ECFS Gene Modifier Working Group
      • ECFS Non Tuberculous Mycobacteria Working Group
  • CARE
    • ECFS Standards Of Care
    • ECFS Working Groups
      • Exercise
      • Diagnostic Network
      • Neonatal Screening
      • Mental Health
      • Fungal Pathogens
      • Pulmonary Exacerbation
      • Telehealth
      • ECFS Intestinal Organoid Working Group
      • Intestinal Organoid Working Group
    • Allied Health Professionals
      • ECFS Nursing Special interest Group
      • European CF Pharmacy Group
      • European Cystic Fibrosis Nutrition Group
      • European Psychosocial Special Interest Group
      • ECFS Physiotherapy Special Interest International Group
  • EDUCATION
  • CONFERENCES & EVENTS
    • European Cystic Fibrosis Conference
    • ECFS Basic Science Conference
    • Related events
    • Past ECFS conferences
  • PUBLICATIONS
    • About Publications
      • The Journal of Cystic Fibrosis
      • ECFS Newsletter
      • ECFS Book
      • ERS Monograph
    • Resources
      • Search All Resources
      • CF Research News
      • Consensus Reports
      • ECFS Guidelines
      • Free Access Articles
      • CF Literature
  • MEMBERSHIP
  • LOG IN

Other Guidelines

Research updates in cystic fibrosis related diabetes: Understanding pathophysiology, expanding animal and human islet models, and advancing clinical and translational research

  • Read more about Research updates in cystic fibrosis related diabetes: Understanding pathophysiology, expanding animal and human islet models, and advancing clinical and translational research

Cystic Fibrosis Year in Review 2025

  • Read more about Cystic Fibrosis Year in Review 2025

Changes in Body Weight and Cholesterol After Starting ETI: A Scoping Review

  • Read more about Changes in Body Weight and Cholesterol After Starting ETI: A Scoping Review

How many exacerbations someone had last year predicts how many they will have this year, even when taking a modulator

  • Read more about How many exacerbations someone had last year predicts how many they will have this year, even when taking a modulator

Therapeutic hopes for CFTR-related pancreatitis

  • Read more about Therapeutic hopes for CFTR-related pancreatitis

What Influences COVID-19 Severity After Transplant: Lessons From a Global Study

  • Read more about What Influences COVID-19 Severity After Transplant: Lessons From a Global Study

Is the multiple breath washout test reproducible in adults with cystic fibrosis?

  • Read more about Is the multiple breath washout test reproducible in adults with cystic fibrosis?

Different Drugs, Different Results: What New CF Treatments Can Offer

  • Read more about Different Drugs, Different Results: What New CF Treatments Can Offer

Pancreatic cysts in people with cystic fibrosis: why diagnosis can be difficult, with patient cases and a review of previous studies

  • Read more about Pancreatic cysts in people with cystic fibrosis: why diagnosis can be difficult, with patient cases and a review of previous studies

Impact of elexacaftor/tezacaftor/ivacaftor on gastrointestinal health in children with cystic fibrosis

  • Read more about Impact of elexacaftor/tezacaftor/ivacaftor on gastrointestinal health in children with cystic fibrosis
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • next
  • last
Terms & Conditions Privacy policy  Accessibility Sitemap Contact 
© EUROPEAN CYSTIC FIBROSIS SOCIETY 2026. All rights reserved. Website by VidaVia (link is external)
European Cystic Fibrosis Society (ECFS)